Cover Image

Treatment of scleromyxedema with IVIg

Saved in:

Bibliographic Details
Main Authors:	Moser David W (Author), Griffin Thomas A (Author)
Format:	Book
Published:	BMC, 2012-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Scleromyxedema: An atypical case
by: Emy Thomas, et al.
Published: (2015)

Dwa przypadki scleromyxedema
by: Jadwiga Dwilewicz-Trojaczek, et al.
Published: (2011)

Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone
by: Sara Saniee, et al.
Published: (2016)

An unusual case of granulomatous scleromyxedema
by: Lauren Michelle, BA, et al.
Published: (2022)

A refractory case of scleromyxedema
by: Sudhir U K Nayak, et al.
Published: (2018)

Coexistence of scleromyxedema and Sneddon syndrome
by: Antonio Furci, MD, et al.
Published: (2021)

Dermoscopic and Cytological Findings in Scleromyxedema
by: Tuğba Tehçi, et al.
Published: (2023)

Localized Scleromyxedema Masquerading as Angioedema
by: Veena Ganiger, et al.
Published: (2024)

Scleromyxedema clinically resembling to scleroderma
by: Megumi Aoki, et al.
Published: (2016)

Scleromyxedema, a therapeutic dilemma
by: Julio Cesar Salas-Alanis, et al.
Published: (2015)

Eczematous reaction to IVIG for the treatment of dermatomyositis
by: J. Berk-Krauss, et al.
Published: (2018)

Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin
by: M. Dolenc-Voljč, et al.
Published: (2013)

MIS-C Treatment: Is IVIG Always Necessary?
by: Francesco Licciardi, et al.
Published: (2021)

A rare case of tumoral scleromyxedema
by: Ali Sadeghinia, et al.
Published: (2020)

Severe cutaneous scleromyxedema treated by lenalidomide
by: Théo Brochet, et al.
Published: (2023)

Plasma cell myeloma masquerading as scleromyxedema
by: Varun Victor, et al.
Published: (2019)

Scleromyxedema: clinical diagnosis and autopsy findings
by: Ana Carolina Bulhões Sala, et al.
Published: (2016)

ARNDT gottron scleromyxedema: Successful response to treatment with steroid minipulse and methotrexate
by: Mehta Vandana, et al.
Published: (2009)

Corrigendum: MIS-C Treatment: Is IVIG Always Necessary?
by: Francesco Licciardi, et al.
Published: (2022)

A case of scleromyxedema responding to lenalidomide and dexamethasone
by: Sweta Rambhia, et al.
Published: (2017)

Paraneoplastic atypical scleromyxedema with advanced gastric cancer
by: Se Jin Oh, MD, et al.
Published: (2017)

Scleromyxedema: A Case Report and Review of the Literature
by: Mohamed Allam, et al.
Published: (2013)

Clinical Characteristics and Treatment Outcomes of Scleromyxedema: A 10-Year Retrospective Survey
by: Abtin Ansari, et al.
Published: (2022)

A rare association of scleromyxedema with cutis verticis gyrata
by: Savita Koregol, et al.
Published: (2016)

Doughnut Sign: A Tell-Tale Sign of Scleromyxedema
by: Akriti Agrawal, et al.
Published: (2024)

Escleromixedema associado a miocardiopatia Scleromyxedema with associated cardiomyopathy
by: Gladys Aires Martins, et al.
Published: (2004)

Treatment of a Complex Case of Scleromyxedema Using a Novel Intravenous Immunoglobulin Preparation
by: Anastasia Sophie Vollmer, et al.
Published: (2024)

IVIG-Associated Maternal Pancytopenia during Treatment for Neonatal Alloimmune Thrombocytopenia
by: Alyssa Herrmann, et al.
Published: (2017)

IVIG Treatment Response and Age are Important for the Prognosis of Pediatric Immune Thrombocytopenia
by: Min Gi Sakong, et al.
Published: (2022)

Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome
by: Chainani Ashok, et al.
Published: (2011)

IVIG Effects on Erythrocyte Sedimentation Rate in Children
by: Farhad Salehzadeh, et al.
Published: (2014)

Positive hepatitis B serology following IVIg treatment in a patient with mucous membrane pemphigoid
by: Ryan Colakovic, BS, et al.
Published: (2021)

Intravenous Immunoglobulin G (IVIG) Need Assessment Survey Toward Local Manufacturing of IVIG Using a Mini-Pool Plasma Fractionation Technique
by: Bisrat Bekele, et al.
Published: (2023)

Cost-minimisation analysis of plasma exchange versus IVIg in the treatment of autoimmune neurological conditions
by: Tara Klemencic Kozul, et al.
Published: (2022)

Discrete Papular Lichen Myxedematosus and Scleromyxedema with Hypothyroidism: A Report of Two Cases
by: Adele Shenoy, et al.
Published: (2019)

Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin
by: Donglin Zhang, BA, et al.
Published: (2023)

IVIG induced Hemolytic anemia - A report of two cases
by: Putun Patel, et al.
Published: (2017)

The effects of hair regrowth with intravenous immunoglobulin (IVIG) therapy. Two case reports
by: Joseph A. Cahill, et al.
Published: (2017)

Absence of Anti-Babesia microti antibody in commercial intravenous immunoglobulin (IVIG).
by: Julia Kostka, et al.
Published: (2024)

Retreatment with intravenous immunoglobulin (IVIG) of refractory Guillain Barre syndrome in children
by: Rivas Larrauri Francisco, et al.
Published: (2014)